Anti-C1orf61 monoclonal antibody

Pre-made anti-C1orf61 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to C1orf61/C1orf61 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2860-Ab-1/ GM-Tg-hg-IP2860-Ab-2Anti-Human C1orf61 monoclonal antibodyHuman
GM-Tg-rg-IP2860-Ab-1/ GM-Tg-rg-IP2860-Ab-2Anti-Rat C1orf61 monoclonal antibodyRat
GM-Tg-mg-IP2860-Ab-1/ GM-Tg-mg-IP2860-Ab-2Anti-Mouse C1orf61 monoclonal antibodyMouse
GM-Tg-cynog-IP2860-Ab-1/ GM-Tg-cynog-IP2860-Ab-2Anti-Cynomolgus/ Rhesus macaque C1orf61 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2860-Ab-1/ GM-Tg-felg-IP2860-Ab-2Anti-Feline C1orf61 monoclonal antibodyFeline
GM-Tg-cang-IP2860-Ab-1/ GM-Tg-cang-IP2860-Ab-2Anti-Canine C1orf61 monoclonal antibodyCanine
GM-Tg-bovg-IP2860-Ab-1/ GM-Tg-bovg-IP2860-Ab-2Anti-Bovine C1orf61 monoclonal antibodyBovine
GM-Tg-equg-IP2860-Ab-1/ GM-Tg-equg-IP2860-Ab-2Anti-Equine C1orf61 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2860-Ab-1/ GM-Tg-hg-IP2860-Ab-2; GM-Tg-rg-IP2860-Ab-1/ GM-Tg-rg-IP2860-Ab-2;
GM-Tg-mg-IP2860-Ab-1/ GM-Tg-mg-IP2860-Ab-2; GM-Tg-cynog-IP2860-Ab-1/ GM-Tg-cynog-IP2860-Ab-2;
GM-Tg-felg-IP2860-Ab-1/ GM-Tg-felg-IP2860-Ab-2; GM-Tg-cang-IP2860-Ab-1/ GM-Tg-cang-IP2860-Ab-2;
GM-Tg-bovg-IP2860-Ab-1/ GM-Tg-bovg-IP2860-Ab-2; GM-Tg-equg-IP2860-Ab-1/ GM-Tg-equg-IP2860-Ab-2
Products NameAnti-C1orf61 monoclonal antibody
Formatmab
Target NameC1orf61
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-C1orf61 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2860-Ag-1Recombinant multi-species CROC4/ C1orf61 protein


    Target information

    Target IDGM-IP2860
    Target NameC1orf61
    Gene ID10485,106992893,102150419
    Gene Symbol and SynonymsC1H1orf61,C1orf61,C5H1orf61,CROC4,MIR9-1HG
    Uniprot AccessionQ13536
    Uniprot Entry NameCROC4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000125462
    Target ClassificationN/A

    The target: C1orf61, gene name: C1orf61, also named as CROC4. Involved in positive regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.